-
A broad-spectrum, parenteral, cephalosporin with activity against both gram-positive and gram-negative bacteria has been approved by the FDA. Ceftaroline fosamil is the prodrug of ceftaroline and is marketed by Forest Pharmaceuticals as Teflaro™.
-
-
In a two-year study, postmenopausal women randomized to nitroglycerin ointment group had significant increases in areal BMD at the lumbar spine, total hip, and femoral neck and decreased bone resorption.
-
The Wells rule for identifying patients at high risk for DVT did not perform as well as one developed from an outpatient population.
-
Compared with manual, automated blood pressure measurements significantly reduced the white coat response in otherwise healthy primary care patients with systolic hypertension while demonstrating a stronger correlation with awake ambulatory blood pressure readings.
-
-
-
In this issue: Apixaban and rivaroxaban near approval for nonvalvular atrial fibrillation; fidaxomicin for C. difficile infections; guideline for intensive insulin therapy; and FDA Actions.
-
Community acquired pneumonia "bundles" often include the use of the pneumococcal urinary antigen assay, but how useful is it for streamlining antibacterial use?
-
A retrospective chart review of all patients admitted to a tertiary care children's hospital in Denver between 2004 and 2009 with orbital infections confirmed by CT scan was performed.